Ultra-early proteomic signatures predict MASLD up to 16 years ahead

Nature Aging · Published 2026-07-30 · DOI 10.1038/s43587-026-01182-3

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s43587-026-01182-3

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Senescent cells cluster CTCF on nuclear speckles to instruct an alternative splicing program · Nature Aging · 2026 · Same journal
Tissue softness unlocks regeneration · Nature Aging · 2026 · Same journal
Targeting interleukin-11 to slow ovarian aging · Nature Aging · 2026 · Same journal
A need for pragmatism in preclinical aging and longevity research · Nature Aging · 2026 · Same journal
An open competition for biomarkers of aging · Nature Aging · 2026 · Same journal
Mapping and manipulating aged and senescent microglia · Nature Aging · 2026 · Same journal
Spatial mapping and senolytic targeting of senescent and disease-associated microglia in aged mouse brain white matter · Nature Aging · 2026 · Same journal
Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset · Nature Aging · 2026 · Same journal
Are GLP-1 receptor agonists gerotherapeutics or just treatments for obesity? · Nature Aging · 2026 · Same journal
Questions of the future in aging and longevity research at the GIMM Festival · Nature Aging · 2026 · Same journal